Compare INNIO N.V. Ordinary Shares (INIO) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
INNIO N.V. Ordinary Shares vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? INNIO N.V. Ordinary Shares trades at $15.9 (market cap $12.38B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B). The key difference: INNIO N.V. Ordinary Shares is the larger of the two by market cap, and INNIO N.V. Ordinary Shares is more actively traded (6,733,708 versus 2,027,457). Which is the better fit depends on your goals — on Pluang, investors hold INNIO N.V. Ordinary Shares for 0 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| INIO | IONS | |
|---|---|---|
Market Cap | $12.38B | $7.10B |
Volume | 6,733,708 | 2,027,457 |
Sector | Industrials | Health |
52-Week High | $41.13 | $86.50 |
52-Week Low | $16.50 | $42.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.04B | $6.66B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About INNIO N.V. Ordinary Shares
INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
